General health checks don't work: It's time to let them go

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Gøtzsche, Peter C ^a   Jørgensen, Karsten Juhl ^a   Krogsbøll, Lasse T ^a  

^a Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

PIOGLITAZONE; ROSIGLITAZONE; TOLBUTAMIDE;

BLADDER CANCER; CARDIOVASCULAR RISK; CAUSE OF DEATH; CLINICAL PRACTICE; CLINICAL RESEARCH; DOCTOR PATIENT RELATION; EDITORIAL; EUROPE; FALLING; GENERAL HEALTH CHECK; HEART FAILURE; HEART INFARCTION; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; LIFESTYLE MODIFICATION; MASS SCREENING; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; SMOKING; SOCIAL STATUS; UNITED STATES;

DIRECTIVE COUNSELING; FEMALE; HUMANS; LIFE STYLE; MALE; MYOCARDIAL ISCHEMIA;

EID: 84902449705     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g3680     Document Type: Editorial

References (9)

1. Krogsbøll LT, Jørgensen KJ, Grønhøj Larsen C, Gøtzsche PC. General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database Syst Rev 2012;10:CD009009.
2. Krogsbøll LT, Jørgensen KJ, Grønhøj Larsen C, Gøtzsche PC. General health checks in adults for reducing morbidity and mortality from disease: Cochrane systematic review and meta-analysis. BMJ 2012;345:e7191.
3. Jørgensen T, Jacobsen RK, Toft U, Aadahl M, Glümer C, Pisinger C. Effect of screening and lifestyle counselling on incidence of ischaemic heart disease in general population: Inter99 randomised trial. BMJ 2014;348:g3617.
4. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev 2013;5:CD000165.
5. Nissen SE. Cardiovascular effects of diabetes drugs: emerging from the dark ages. Ann Intern Med 2012;157:671-2.
6. Nissen SE, Wolski K. Effect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causes. N Engl J Med 2007;356:2457-71.
7. Moynihan R. Rosiglitazone, marketing, and medical science. BMJ 2010;340:c1848.
8. Hillaire-Buys D, Faillie JL. Pioglitazone and the risk of bladder cancer. BMJ 2012;344:e3500.
9. Beswick AD, Rees K, Dieppe P, Ayis S, Gooberman-Hill R, Horwood J, et al. Complex interventions to improve physical function and maintain independent living in elderly people: a systematic review and meta-analysis. Lancet 2008;371:725-35.